A 12-week Safety & Efficacy Study of Beclomethasone Dipropionate (80 & 160

A 12-week Safety and Efficacy Study of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Patients >=12 Years Old With Persistent Asthma

Persistent Asthma Clinical Trial

Official title:
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week Clinical Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma

Status Completed

Clinical Trial Summary

This is a randomized, double-blind, placebo-controlled parallel-group study. Participants will be randomly assigned to receive treatment with beclomethasone dipropionate at a dosage of 80 or 160 mcg/day delivered via a Breath-Actuated Inhaler (BAI); or a matching BAI placebo, in a 1:1:1 ratio after a 14- to 21-day run-in period. Participants and investigators will remain blinded to randomized treatment assignment during the study

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02040779
Study type	Interventional
Source	Teva Branded Pharmaceutical Products R&D, Inc.
Contact
Status	Completed
Phase	Phase 3
Start date	December 26, 2013
Completion date	December 24, 2014

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02513160` - Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma	Phase 3
Active, not recruiting	`NCT02883530` - Refractory Asthma Stratification Programme (RASP) Bronchoscopy Study
Completed	`NCT02003521` - Impact of Lung Flute Therapy on Asthma	N/A
Completed	`NCT01253603` - Efficacy, Safety, and Pharmacokinetics of QAW039	Phase 2
Completed	`NCT01845025` - Study of Safety of Foradil in Patients With Persistent Asthma	Phase 4
Not yet recruiting	`NCT02053402` - Effect of Vitamin D Supplementation on the Control of Asthma in Children at a South African Academic Hospital	Phase 4
Completed	`NCT01156844` - Efficacy, Safety and Pharmacokinetics of Different Regimens of Indacaterol	Phase 2
Completed	`NCT01078688` - Evaluation of the Frequency of Limitation of Activity in Patients With Persistent Asthma	N/A
Completed	`NCT02176694` - Adolescent Controlled Text Messaging to Improve Asthma Medication Adherence in Primary Care	N/A
Completed	`NCT02026336` - E-nose and Inflammatory Asthma Phenotypes	N/A
Withdrawn	`NCT04271839` - Efficiency Control of Fluticasone/Formoterol K-haler (Medium Strength) vs ICS/LABA (High Strength) in Asthma Patients	Phase 4
Active, not recruiting	`NCT04480242` - Asthma Research in Children and Adolescents
Completed	`NCT02175771` - Long-Term Safety Study of Fluticasone Propionate (Fp) Multidose Dry Powder Inhaler (MDPI) and Fluticasone Propionate/Salmeterol (FS) MDPI in Patients With Persistent Asthma	Phase 3
Completed	`NCT01147510` - Asthma Control in Elderly Patients With Montelukast	Phase 4
Completed	`NCT03541187` - Cockroach Immunotherapy in Children and Adolescents	Phase 2
Active, not recruiting	`NCT05843045` - Indoor Air Quality Asthma Study: The Effect of Indoor Air Quality and Mitigation of Same on Persistent Asthma	N/A